Position in BMY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$225,529,633
-$108,469,672 QoQ
Shares Held
3,914,086
-28.9% QoQ
Ownership
0.192%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#66
of 2,514 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 98%
None 2%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026WELLINGTON MANAGEMENT GROUP LLP holds $41,461,553,100 across 12 Drug Manufacturers - General names. BMY ranks #11 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
10,998,953 | $13,192,475,293 | |
| 2 | MRK |
Merck & Co., Inc.
|
86,249,283 | $11,083,032,864 | |
| 3 | JNJ |
Johnson & Johnson
|
22,588,696 | $5,736,851,118 | |
| 4 | AZN |
Astrazeneca PLC
|
28,537,243 | $5,411,232,013 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
12,699,683 | $1,604,477,945 | |
| 6 | ABBV |
AbbVie Inc.
|
5,055,589 | $1,272,188,413 | |
| 7 | AMGN |
Amgen Inc
|
2,742,271 | $993,031,171 | |
| 8 | BIIB |
Biogen Inc.
|
3,117,469 | $673,560,350 |
All Filings in BMY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $225,529,633 | 3,914,086 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $333,999,305 | 5,506,996 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $373,346,138 | 6,921,508 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $773,737,808 | 17,156,049 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $1,195,363,192 | 25,823,357 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,447,197,736 | 23,728,443 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $338,087,680 | 5,977,505 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $7,770,725 | 150,188 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $6,923,299 | 166,706 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $15,564,387 | 287,007 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $221,789,116 | 4,322,532 | Shares | Defined | 2024-02-12 | |
| 2023-09-30 | $264,569,765 | 4,558,404 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $294,095,369 | 4,598,833 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $320,794,470 | 4,628,401 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $641,757,159 | 8,919,488 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $2,373,407,609 | 33,385,956 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $2,753,535,015 | 35,760,195 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $3,105,386,038 | 42,522,060 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $3,126,697,807 | 50,147,519 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $2,686,753,723 | 45,407,364 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $2,937,611,665 | 43,963,060 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $2,706,927,214 | 42,878,619 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $2,837,467,751 | 45,743,475 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $3,254,961,054 | 53,988,407 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $3,742,724,192 | 63,651,772 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $4,208,830,464 | 75,508,261 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||